Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07645144
FES-assisted Gait Training for Incomplete Spinal Cord InjuryStichting ReadeEnrolling By InvitationNot Applicable
NCT07645144Enrolling By Invitation
Not Applicable
FES-assisted Gait Training for Incomplete Spinal Cord InjuryStichting Reade
NCT07644936
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisNot Yet Recruiting
NCT07644936Not Yet Recruiting
—
Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachAzienda Ospedaliera Speci...
NCT07644143
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical UniversityNot Yet RecruitingNot Applicable
NCT07644143Not Yet Recruiting
Not Applicable
Effect of A Theory-based Multicomponent eHealth Intervention ProgramTaipei Medical University
NCT07645950
Effect of the MIROKI Companion Robot on Anxiety in Pediatric RadiotherapyInstitut du Cancer de Montpellier - Val d'AurelleNot Yet Recruiting
NCT07645950Not Yet Recruiting
—
Effect of the MIROKI Companion Robot on Anxiety in Pediatric RadiotherapyInstitut du Cancer de Mon...
NCT07644299
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Concept StudyCiusss de L'Est de l'Île de MontréalNot Yet RecruitingNot Applicable
NCT07644299Not Yet Recruiting
Not Applicable
Self-Hypnosis Training for Migraine Management (HYlaMI): A Pilot and Proof-of-Co...Ciusss de L'Est de l'Île...
NCT07646327
Sustained Natural Apophyseal Glides With and Without Facilitated Positional Release Technique in Cervicogenic DizzinessRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07646327Not Yet Recruiting
Not Applicable
Sustained Natural Apophyseal Glides With and Without Facilitated Positional Rele...Riphah International Univ...
NCT07645469
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid LeukemiaFred Hutchinson Cancer CenterNot Yet RecruitingPhase 1
NCT07645469Not Yet Recruiting
Phase 1
FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Di...Fred Hutchinson Cancer Ce...
NCT07644754
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of MunichNot Yet RecruitingNot Applicable
NCT07644754Not Yet Recruiting
Not Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level...Ludwig-Maximilians - Univ...
NCT07645157
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital of Chongqing Medical UniversityRecruitingPhase 2
NCT07645157Recruiting
Phase 2
Sertraline Combined With Multi-Strain Probiotics for Adolescent DepressionFirst Affiliated Hospital...
NCT07644416
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana UniversityNot Yet RecruitingNot Applicable
NCT07644416Not Yet Recruiting
Not Applicable
Using Virtual Reality Travel to Reduce Loneliness in Older AdultsIndiana University
NCT07645859
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuous Training in Chronic Non-Specific Low Back Pain PatientsDow University of Health SciencesRecruitingNot Applicable
NCT07645859Recruiting
Not Applicable
Comparison of High-Intensity Interval Training With Moderate-Intensity Continuou...Dow University of Health...
NCT07643805
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityNot Yet RecruitingPhase 1
NCT07643805Not Yet Recruiting
Phase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Pat...The First Affiliated Hosp...
NCT07646548
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy ParticipantsRegeneron PharmaceuticalsNot Yet RecruitingPhase 1
NCT07646548Not Yet Recruiting
Phase 1
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Be...Regeneron Pharmaceuticals
NCT07643909
Health-Related Social Needs Food Boxes Delivery ProgramBoston Medical CenterNot Yet RecruitingNot Applicable
NCT07643909Not Yet Recruiting
Not Applicable
Health-Related Social Needs Food Boxes Delivery ProgramBoston Medical Center
NCT07644767
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty LtdNot Yet RecruitingPhase 2
NCT07644767Not Yet Recruiting
Phase 2
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty Lt...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07646054
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.Not Yet RecruitingNot Applicable
NCT07646054Not Yet Recruiting
Not Applicable
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.
NCT07644923
Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated CoagulationNYU Langone HealthNot Yet RecruitingPhase 4
NCT07644923Not Yet Recruiting
Phase 4
Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled Wit...NYU Langone Health
NCT07644039
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPharmaMarRecruitingPhase 1
NCT07644039Recruiting
Phase 1
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advan...PharmaMar
Result Breakdown
Not yet recruiting15 (75%)
Recruiting4 (20%)
Enrolling by invitation1 (5%)
not_applicable9 (45%)
Phase 14 (20%)
Phase 23 (15%)
Not Specified2 (10%)
Phase 42 (10%)